2Writing Group for the women's health initiative investigators.Risks and benefits of estrogen plus progestin in healthy postmenopausal women[J].JAMA,2002,288(22):32.
3Fletcher SW,Colditz GA.Failure of estrogen plus progestin therapy for prevention[J].JAMA,2002,288(3):366.
4Paganini-Hill A.Hormone replacement therapy and stroke:risk,protection or no effect?[J].Maturitas,2001,38(3):243.
5Simon JA,Hsia J,Cauley JA,et al.Postmenopausal hormone therapy and risk of stroke:The Heart and Estrogen/Progestin Replacement Study (HERS)[J].Circulation,2001,103(5):638.
6The Writing Group of the IMS Executive Committee.Guidelines for the hormone treatment of women in the menopausal transition and beyond[J].Climacteric,2004,7(4):8.
7Haines CJ,Xing SM,Park KH,et al.Prevalence of menopausal symptoms in different ethnic group of Asian woman and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate:The Pan-Asia menopause(PAM) study[J].Maturitas,2005,52(3/4):264.
